Mitochondria session-7: Mitochondria in age-related diseases - part II
Tracks
Track 1
Friday, May 23, 2025 |
11:00 - 12:30 |
Details
ORGANIZERS
ESCI Council: Mariusz Wieckowski and Paulo Oliveira
ESCI YRC: Felippe Zuccolotto Dos Reis, Stefano Ministrini
Invited Organizer(s): Michelangelo Campanella
Speaker
Michele Visentin
Group Leader
University Hospital Zurich
Mitochondria in drugs-related adverse effects
11:00 - 11:25Biography
I earned a bachelor’s degree in molecular biology from the University of Padua, a master’s degree in molecular medicine from the University of Trieste. I obtained my PhD degree in biochemistry and pharmacology from the University of Udine. As a postdoc, I worked for 4 years in the department of molecular pharmacology at the Albert Einstein Medical College of New York, and 4 years in the department of Clinical Pharmacology and Toxicology at the University Hospital Zurich. Currently, I am a Research Group Leader in the department of Clinical Pharmacology and Toxicology at the University Hospital Zurich and a lecturer in Experimental Pharmacology and Toxicology at the University of Zurich. Our laboratory of experimental pharmacology and toxicology aims to address two overlapping but distinct questions: (i) What are the molecular determinants that define drug tropism? (ii) What is the role of mitochondria in drug toxicity?
Felippe Zuccolotto
Frontiers in Molecular and Cellular Oncology
Title is pending
11:25 - 11:50Biography
Chair
Werner J.H. Koopman
Associate Professor And Group Leader
Radboud University Medical Center
Marie-Luce Vignais
Institut de Génomique Fonctionnelle-CNRS
